Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis

Liu, Yang; Pan, Zhengmei; Wu, Yanzhi; Song, Jiamei; Chen, Jingsi

doi:10.1186/s13048-023-01202-5

Table 1 Characteristics of the studies included of AMH for predicting ovarian response

From: Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis

Author	Region	Definition of ovarian response	TP	FP	FN	TN	Cut-off
Poor response
Li et al. 2016 [41]	China	≤ 5 oocytes	23	47	21	321	1.1 ng/ml
Fouda et al. 2010 [27]	Egypt	< 3 follicles	8	18	2	32	0.9 ng/ml
Singh et al. 2013 [51]	India	< 4 oocytes	8	9	2	36	NS
Martínez et al. 2013 [42]	Spain	< 6 oocytes	19	29	8	47	2.31 ng/ml
Baker et al. 2018 [22]	USA	≤ 4 oocytes	20	13	7	120	0.93 ng/ml
Kamel et al. 2014 [57]	Egypt	NS	30	1	5	74	2.8ug/l
Fabregues et al. 2018 [25]	Spain	≤ 3 oocytes	43	77	8	310	NS
Heidar et al. 2015 [30]	Iran	≤ 3 oocytes	16	32	6	134	1.2 ng/ml
Ashrafi et al. 2017 [20]	Iran	≤ 4 oocytes	90	116	32	312	1.05 ng/ml
Neves et al. 2020 [48]	Belgium^a	≤ 3 oocytes	46	56	4	113	1.00 ng/ml
Islam et al. 2016 [31]	Egypt	≤ 3 oocytes	9	40	6	45	1.4 ng/ml
Baker et al. 2021 [21]	USA, Canada	≤ 4 oocytes	47	43	27	355	0.93 ng/ml
Palhares et al. 2018 [17]	Brazil	≤ 3 oocytes	36	41	9	55	1.5 ng/ml
Jayaprakasan et al. 2010 [34]	UK	≤ 3 oocytes	15	32	0	88	0.99 ng/ml
Tolikas et al. 2011 [18]	Greece	< 4 oocytes	20	18	9	43	2.74 ng/ml
Tremellen et al. 2005 [54]	Australia	≤ 4 oocytes	16	8	4	47	8.1 pmol/l
Kunt et al. 2011 [37]	Turkey	< 5 oocytes	46	14	0	120	2.97 ng/ml
Marca et al. 2007 [38]	Italy	< 4 oocytes	10	3	2	33	0.75 ng/ml
Mutlu et al. 2013 [10]	Turkey	< 4 oocytes	34	20	15	123	0.94 ng/ml
Peñarrubia et al. 2005 [49]	Spain	< 3 follicles	11	2	9	58	4.9 pmol/l
Nardo et al. 2009 [46]	UK	< 4 follicles	13	50	2	101	1.00 ng/ml
Fiçicioglu et al. 2006 [26]	Turkey	< 5 follicles	10	3	1	30	0.25 pg/ml
McIlveen et al. 2007 [43]	UK	≤ 4 oocytes	11	26	2	45	1.25 ng/ml
Muttukrishna et al. 2004 [44]	UK	< 4 follicles	15	14	2	38	0.1 ng/ml
Nakhuda et al. 2007 [45]	USA	NS	20	8	2	36	0.35 ng/ml
Gnoth et al. 2008 [29]	Germany	≤ 4 oocytes	32	58	1	41	1.26 ng/ml
Nelson et al. 2007 [47]	UK	≤ 2 oocytes	14	29	5	292	5 pmol/l
van Rooij et al. 2002 [55]	Netherlands	< 4 oocytes	21	9	14	75	0.3 ng/ml
Lee et al. 2011 [39]	Taiwan	NS	11	16	6	93	0.68 ng/ml
High response
Li et al. 2016 [41]	China	> 15 oocytes	165	149	38	219	2.6 ng/ml
Akbari Sene et al. 2021 [50]	Iran	> 15 oocytes	31	16	10	43	4.95 ng/ml
Izhar et al. 2021 [32]	Pakistan	NS	50	14	4	208	6.43 ng/ml
Tan et al. 2021 [53]	China	> 15 oocytes	137	15	30	154	3.6 ng/ml
Heidar et al. 2015 [30]	Iran	> 12 oocytes	30	34	23	93	3.40 ng/ml
Ashrafi et al. 2017 [20]	Iran	≥ 15 oocytes	79	129	40	302	2.5 ng/ml
Vembu et al. 2017 [11]	India	≥ 20 oocytes	11	15	2	132	4.85 ng/ml
Neves et al. 2020 [48]	Belgium^a	> 15 oocytes	13	16	11	179	2.25 ng/ml
Nardo et al. 2009 [46]	UK	> 20 oocytes	14	45	2	104	3.5 ng/ml
Eldar-Geva et al. 2005 [24]	Israel	> 20 oocytes	12	4	5	35	3.5 ng/ml
Aflatoonian et al. 2009 [19]	Iran	> 15oocytes	42	22	3	76	34.5 pmol/l
Lee et al. 2008 [40]	China	NS	19	45	2	196	3.36 ng/ml
Nelson et al. 2007 [47]	UK	≥ 21 oocytes	15	16	10	299	25 pmol/l

NS Not stated, TP True positive, FP False positive, FN False negative, TN True negative
^aRegion included Belgium, Spain, Germany, Italy

Back to article page

ISSN: 1757-2215

Contact us

General enquiries: journalsubmissions@springernature.com

Journal of Ovarian Research

Contact us